Capricor Therapeutics
CAPR
#7976
Rank
S$0.37 B
Marketcap
S$8.24
Share price
-4.36%
Change (1 day)
-59.22%
Change (1 year)

Capricor Therapeutics (CAPR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$55.17 Million

According to Capricor Therapeutics 's latest financial reports the company's total liabilities are S$55.17 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Capricor Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$34 M-28.74%
2023-12-31S$47.72 M-7.08%
2022-12-31S$51.35 M281.32%
2021-12-31S$13.46 M58.6%
2020-12-31S$8.49 M47.37%
2019-12-31S$5.76 M-8.93%
2018-12-31S$6.32 M-6.27%
2017-12-31S$6.75 M-79.5%
2016-12-31S$32.92 M36.12%
2015-12-31S$24.19 M-7.91%
2014-12-31S$26.26 M241.42%
2013-12-31S$7.69 M1088.98%
2012-12-31S$0.64 M-7.71%
2011-12-31S$0.7 M-49.08%
2010-12-31S$1.37 M53.86%
2009-12-31S$0.89 M-53.01%
2008-12-31S$1.9 M-29.95%
2007-12-31S$2.71 M1215.56%
2006-12-31S$0.2 M59.33%
2005-12-31S$0.12 M33.86%
2004-12-31S$0.09 M36.56%
2003-12-31S$0.07 M66.55%
2002-12-31S$0.04 M150.57%
2001-12-31S$0.01 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Cytokinetics
CYTK
S$2.53 B 4,498.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
S$13.11 M-76.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$147.15 B 266,605.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$1.63 B 2,864.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$64.9 M 17.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S$3.37 M-93.89%๐Ÿ‡บ๐Ÿ‡ธ USA